Purchase Order 75D30121P12247
Award Date
8/13/21
Potential Completion Date
8/29/23
Potential Value
$51K
Federal Agency
CDC Pittsburgh
Awardee
Qiagen, LLC
Ultimate Awardee
Qiagen N.V.
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a subsidiary of the Qiagen N.V. biotechnology company. The $113,138.05 contract is for the provision of QIACUBE HT/QIAXTRACTOR platform equipment, which supports the CDC's biomedical research, public health, and healthcare programs. Qiagen is a well-established federal contractor, holding multiple indefinite delivery vehicles (IDVs) and blanket purchase agreements (BPAs) with...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Qiagen, LLC, a division of Qiagen N.V., for the acquisition of QIAGEN equipment and reagents. The contract, valued at $134,538.38, does not have a set-aside designation. Qiagen N.V. is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic research. The company has a history of supporting federal...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $205,000 purchase order to Qiagen, LLC for their EZ! ADVANCED XL SYSTEM. Qiagen, a subsidiary of Qiagen N.V., will provide its sample preparation and nucleic acid extraction platform to support CDC programs through a one-month period of performance ending in late August 2023. The firm fixed price contract calls for Qiagen to deliver its proprietary system to help CDC process samples...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $57,348.26 firm fixed-price purchase order contract to Qiagen, LLC, a division of the international provider Qiagen N.V., for QIACUITY equipment and maintenance services. This contract does not have a set-aside designation. Qiagen has a history of providing products and services, such as DNA/RNA extraction kits, next-generation sequencing, and bioinformatics software, to support federal agencies'...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $79,796.08 firm-fixed-price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the purchase of a QIAGEN EZ2 Connect MDX system. This equipment will support the CDC's biomedical research, public health, and healthcare programs. Qiagen has provided a range of laboratory products and services to various federal agencies in the past, including the Department of Health...
Qiagen, LLC was awarded a purchase order for $66,592.30 by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to provide EZ1 & 2 DNA Tissue Kits, Buffer AL, and Qiagen Proteinase K. No set-aside designation was applied to this contract. Performance will take place in Germantown, Maryland through August 31, 2023. Qiagen, a division of Qiagen N.V., will deliver the requested DNA extraction products to support the Centers for Disease Control and...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $32,000 purchase order to Qiagen, LLC for a QIAGEN ROBOT. Qiagen, LLC is a division of Qiagen N.V., which will serve as the prime contractor to deliver the robotic system to the CDC location in Germantown, Maryland between September 12-29, 2023. The contract has a firm fixed price and will support the CDC's efforts to modernize its laboratory equipment and processes. No major...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $148,000.00 contract is for the delivery of products and services to support the CDC's biomedical research, public health, and healthcare programs. This includes DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, bioinformatics...
This is a $145,237 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract is for "other functions" and does not have a set-aside designation. Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic research. Under this award, Qiagen is likely providing products and services to support the...
The Centers for Disease Control and Prevention (CDC) awarded a $50,613 purchase order contract to Qiagen, LLC to provide products and services in support of the agency's public health programs. As a subsidiary of Qiagen N.V., Qiagen will deliver items from its product catalog to the CDC location in Germantown, Maryland under a firm fixed price arrangement. No additional details were provided on the scope of work. The award draws from the CDC's annual appropriations and advances the agency's...